Different anesthetic techniques have been suggested for craniotomy with intraoperative awakening. We describe an asleep-awake-asleep technique with propofol and remifentanil infusions, with pharmacokinetic simulation to predict the effect-site concentrations and to modulate the infusion rates of both drugs, and bispectral index (BIS) monitoring. Five critical moments were defined: first loss of consciousness (LOC 1 ), first recovery of consciousness (ROC 1 ), final of neurologic testing (NT), second loss of consciousness (LOC 2 ), and second recovery of consciousness (ROC 2 ). At LOC 1 , predicted effect-site concentrations of propofol and remifentanil were, respectively, 3.6±1.2 μg/mL and 2.4±0.4 ηg/mL. At ROC 1 , predicted effect-site concentrations of propofol and remifentanil were, respectively, 2.1±0.3 μg/mL and 1.8±0.3 ηg/mL. At NT, predicted effect-site concentrations of propofol and remifentanil were, respectively, 0.9±0.3 μg/mL and 1.8±0.2 ηg/mL. At LOC 2 , predicted effect-site concentrations of propofol and remifentanil were, respectively, 2.1±0.2 μg/mL and 2.5±0.2 ηg/mL. At ROC 2 , predicted effect-site concentrations of propofol and remifentanil were, respectively, 1.2±0.5 μg/mL and 1.4±0.2 ηg/mL (data are mean±SE). A significative correlation was found between BIS and predicted effect-site concentrations of propofol (r 2 =0.547, P<0.001) and remifentanil (r 2 =0.533, P<0.001). Multiple regression analysis between BIS and propofol and remifentanil predicted effect-site concentrations at the different critical steps of the procedure was done and found also significative (r 2 =0.7341, P<0.001).
Background and Goal of Study: Some published data suggested that inflammation and C-Reactive Protein (CRP) plasmatic concentration might be related with cognitive impairment after cardiac surgery 1 . We hypothesized that anesthetic needs for loss of consciousness (LOC) are influenced by a pre-operative inflammatory state. Materials and Methods: We studied 78 patients, 36 female, age between 21 and 81 years old, ASA I-IV, Glasgow Coma Score 14-15, submitted to brain and non-brain surgery. Anesthetic management for induction of general anesthesia was the same: using RugloopII® software, anesthesia started with TCI of remifentanil with an effect-site target concentration of 2.5 ng/ml and a constant infusion of 1% propofol at 200 ml/hr until LOC; for each patient, predicted effect-site concentration of propofol at LOC was registered. Pre-operative plasmatic concentration of CRP was determined, but until LOC anesthesiologists in charge was blind for that value.Quadratic regression was done to correlate pre-operative plasmatic concentration of CRP and predicted effect-site concentration of propofol at LOC; p Ͻ 0.05 was considered significant. Results: Pre-operative plasmatic concentration of CRP and predicted effectsite concentration of propofol at LOC showed an inverse correlation (r ϭ 0,79, p Ͻ 0.01) (Figure 1). Similar correlations were found when patients were divided into brain surgery group(r ϭ 0,64, p Ͻ 0.01) and non-brain surgery group (r ϭ 0,86, p Ͻ 0.01).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.